Japan Short-Read NGS Data Market was valued at USD 0.4 Billion in 2022 and is projected to reach USD 1.1 Billion by 2030, growing at a CAGR of 14.9% from 2024 to 2030.
The Short-Read NGS (Next Generation Sequencing) Data Market in Japan is experiencing significant growth, fueled by advancements in genomic research and the increasing demand for faster, more efficient sequencing technologies. This market caters to a variety of industries, including healthcare, pharmaceuticals, biotechnology, and academic research, all of which require accurate and reliable genomic data for various applications. As Japan continues to position itself as a leader in biotechnology and genomics, the Short-Read NGS Data Market plays a critical role in driving innovation and supporting scientific breakthroughs.
Industries leveraging short-read sequencing technology are primarily focused on applications such as gene sequencing, disease diagnostics, personalized medicine, and agricultural improvements. With a growing emphasis on precision medicine, there is an increased demand for high-quality genomic data that can be used to tailor medical treatments to individual patients. Furthermore, the pharmaceutical sector relies on short-read NGS data to expedite drug discovery and development processes, particularly in the context of cancer research and rare genetic disorders.
One of the key drivers of the Short-Read NGS Data Market in Japan is the ability to generate high-throughput sequencing results at a relatively low cost compared to traditional methods. This makes it an attractive option for both large-scale research projects and smaller laboratories, creating a broad market for both large and emerging players in the biotechnology space. Additionally, the advent of cloud computing and AI-powered analytics has made it easier for companies to process and analyze large datasets quickly, adding further value to the market.
Moreover, the demand for short-read sequencing is rising as it supports research in genomics, epidemiology, and forensics. Academic institutions and government agencies are investing heavily in NGS technologies to improve public health initiatives and to explore the complexities of the human genome. As Japan's healthcare infrastructure continues to embrace cutting-edge technologies, short-read sequencing is set to become even more pivotal in clinical diagnostics and therapeutic advancements.
Given the fast pace of innovation in the Short-Read NGS Data Market, industries must stay ahead by adopting the latest technologies and integrating new tools for analysis and interpretation. The need for real-time, accurate genomic data will continue to shape market trends, ensuring that Japan remains at the forefront of global genomic research.
Get an In-Depth Research Analysis of the Japan Short-Read NGS Data Market Size And Forecast [2025-2032]
Â
Agilent Technologies
Inc.
BGI Group
DNAnexus
Inc.
Fabric Genomics
Inc.
Hoffmann-La Roche Ltd. (Roche Molecular Systems
Inc.)
Illumina
Inc.
PerkinElmer Inc.
QIAGEN N.V.
Qumulo
Inc.
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Japan Short-Read NGS Data Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Japan Short-Read NGS Data Market
Sequencing Platforms
Sequencing Methods
Clinical Applications
Research Applications
Academic and Research Institutions
Clinical Laboratories
Pharmaceutical and Biotechnology Companies
Hospitals and Healthcare Institutions
Consumables
Instruments
Software
Pre-sequencing
Sequencing
Post-sequencing
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ Japan Short-Read NGS Data Market Research Analysis
1. Introduction of the Japan Short-Read NGS Data Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Japan Short-Read NGS Data Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Japan Short-Read NGS Data Market, By Type
6. Japan Short-Read NGS Data Market, By Application
7. Japan Short-Read NGS Data Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. Japan Short-Read NGS Data Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/